Crossmark

ROS-1 TKI for the treatment of concurrent sarcomatoid transformation and acquired ROS-1 F2004C mutation in a lung adenocarcinoma patient

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2021.08.009

Published Online: 2025-03-10

Published Print: 2022-01-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Ko, H.-J.

Hsu, C.-K.

Yeh, Y.-C.

Huang, H.-C. https://orcid.org/0000-0002-7384-6838
License Information

Version of Record valid from 2022-01-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2021-04-02

Accepted: 2021-08-28

Published: 2025-03-10